Singh M, Pushpakumar S, Bard N, Zheng Y, Homme R, Mokshagundam S
Mol Cell Biochem. 2022; 478(1):103-119.
PMID: 35731343
PMC: 9214689.
DOI: 10.1007/s11010-022-04487-0.
Li Y, Wu H, Liu C
Int J Mol Sci. 2021; 22(17).
PMID: 34502289
PMC: 8431721.
DOI: 10.3390/ijms22179380.
Chung H, Chen X, Yu Y, Lee H, Song C, Choe H
FEBS Open Bio. 2018; 8(1):130-145.
PMID: 29321963
PMC: 5757181.
DOI: 10.1002/2211-5463.12357.
Majumder A, Singh M, Tyagi S
Oncotarget. 2017; 8(60):102739-102758.
PMID: 29254284
PMC: 5731994.
DOI: 10.18632/oncotarget.22156.
Kgatle M, Spearman C, Kalla A, Hairwadzi H
Oxid Med Cell Longev. 2017; 2017:3179421.
PMID: 28740569
PMC: 5504953.
DOI: 10.1155/2017/3179421.
Mouse models of liver cancer: Progress and recommendations.
He L, Tian D, Li P, He X
Oncotarget. 2015; 6(27):23306-22.
PMID: 26259234
PMC: 4695120.
DOI: 10.18632/oncotarget.4202.
Dysplastic hepatocytes develop nuclear inclusions in a mouse model of viral hepatitis.
Thakur P, Lamoke F, Chaffin J, Bartoli M, Lee J, Duncan M
PLoS One. 2014; 9(6):e99872.
PMID: 24932583
PMC: 4059674.
DOI: 10.1371/journal.pone.0099872.
Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.
Maronpot R
J Toxicol Pathol. 2012; 22(1):11-33.
PMID: 22271974
PMC: 3246016.
DOI: 10.1293/tox.22.11.
Hepatocellular carcinoma: insight from animal models.
Li Y, Tang Z, Hou J
Nat Rev Gastroenterol Hepatol. 2011; 9(1):32-43.
PMID: 22025031
DOI: 10.1038/nrgastro.2011.196.
Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.
Park N, Song I, Chung Y
Gut Liver. 2010; 1(2):101-17.
PMID: 20485626
PMC: 2871634.
DOI: 10.5009/gnl.2007.1.2.101.
Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.
Wu M, Ma W, Hsu C, Chen Y, Ou J, Ryan C
Sci Transl Med. 2010; 2(32):32ra35.
PMID: 20484730
PMC: 3032595.
DOI: 10.1126/scitranslmed.3001143.
Experimental models of hepatocellular carcinoma: developments and evolution.
Wu L, Tang Z, Li Y
J Cancer Res Clin Oncol. 2009; 135(8):969-81.
PMID: 19399516
DOI: 10.1007/s00432-009-0591-7.
Mouse models in liver cancer research: a review of current literature.
Leenders M, Nijkamp M, Borel Rinkes I
World J Gastroenterol. 2008; 14(45):6915-23.
PMID: 19058325
PMC: 2773853.
DOI: 10.3748/wjg.14.6915.
Viruses associated with human cancer.
McLaughlin-Drubin M, Munger K
Biochim Biophys Acta. 2008; 1782(3):127-50.
PMID: 18201576
PMC: 2267909.
DOI: 10.1016/j.bbadis.2007.12.005.
Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis.
Barone M, Spano D, dApolito M, Centra M, Lasalandra C, Capasso M
Mol Med. 2006; 12(4-6):115-23.
PMID: 16953557
PMC: 1578771.
DOI: 10.2119/2006-00015.Barone.
HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1.
Mukherji A, Janbandhu V, Kumar V
Biochem J. 2006; 401(1):247-56.
PMID: 16939421
PMC: 1698683.
DOI: 10.1042/BJ20061091.
Chronic hepatitis B in hepatocarcinogenesis.
Park N, Song I, Chung Y
Postgrad Med J. 2006; 82(970):507-15.
PMID: 16891440
PMC: 2585715.
DOI: 10.1136/pgmj.2006.047431.
Replication and gene expression of mutant hepatitis B virus in a transgenic mouse containing the complete viral genome with mutant s gene.
Ge J, Zhang L, Li J, Liu H, Liu H, He J
World J Gastroenterol. 2004; 10(21):3141-5.
PMID: 15457560
PMC: 4611258.
DOI: 10.3748/wjg.v10.i21.3141.
Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice.
Lu L, Zeng M, Mao Y, Fang J, Song Y, Shen Z
World J Gastroenterol. 2004; 10(8):1176-9.
PMID: 15069721
PMC: 4656356.
DOI: 10.3748/wjg.v10.i8.1176.